Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/3f4c5b10-cf09-4c8c-93ea-720f652da9d6/
UNICHEMLAB
Unichem Laboratories LimitedSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
P/E 10.1
◇
VC2 Cheapest
✗
📐
EBITDA/EV
16.2%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
75.0%ile
P/E
10.1×
P/S
1.2×
P/B
0.9×
E/P
0.0989
FCF Yield
-0.043
EBITDA/EV
0.162
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
19.00000000
/100 — 1=cheapest
VC2 (Trending Value)
19.00000000
/100
VC3 (Buyback)
15.00000000
/100
P/E of 10.1x places this firmly in deep value territory. Negative FCF yield (-4.3%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
22.0%ile
ROE
0.093
ROA
0.068
Net Margin
0.115
Op Margin
0.025
GPA
0.316
Current
2.48
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.043
Earn Growth
0.839
Stability
1.905
lower=better
Accruals
0.067
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
6.0%ile
6M Return
-18.5%
12M Return
-38.8%
12-1 Mom
-34.9%
Risk-Adj
-1.02
Vol 252d
34.1%
Vol 60d
70.8%
↑ Expanding
Max DD 12M
-55.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -35% signals a downtrend — price is moving against you. Near-term vol (71%) is expanding vs long-term (34%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.37
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 160 peers
Sector Value %ile
93.8%
Sector Quality %ile
16.1%
P/E z-score
-0.26
P/B z-score
-0.95
Sector Avg OS
43.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
| Symbol | Name | OS | Value | Quality | Momentum |
|---|---|---|---|---|---|
| NATCOPHARM | 98.0% | 88.0% | 87.0% | 81.0% | |
| UNIVPHOTO | 97.0% | 86.0% | 74.0% | 94.0% | |
| LINCOLN | 97.0% | 88.0% | 80.0% | 81.0% | |
| VENUSREM | 96.0% | 68.0% | 94.0% | 99.0% | |
| STAR | 96.0% | 73.0% | 91.0% | 91.0% | |
| HALEOSLABS | 95.0% | 82.0% | 77.0% | 81.0% | |
| AUROPHARMA | 94.0% | 71.0% | 84.0% | 87.0% | |
| SAGILITY | 93.0% | 76.0% | 81.0% | 76.0% |
Factor Interactions
Cheap for a Reason?
Looks cheap (75th value) but weak quality (22th). Classic value trap risk.
Falling Knife
Weak momentum (6th) despite looking cheap (75th value). Wait for momentum to stabilise.
Volatility Expanding
60-day vol (71%) significantly exceeds 252-day (34%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
62.2% avg (7 factors)
Quality
D
44.7% avg (7 factors)
Momentum
F
3.6% avg (4 factors)
Risk
C
59.8% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.370 | —0 | — | |
| Value %ile | 0.750 | —1 | — | |
| Quality %ile | 0.220 | —1 | — | |
| Momentum %ile | 0.060 | —1 | — | |
| F-Score | 6.000 | —0 | — | |
| Confidence | 0.939 | —1 | — | |
| Volatility | 0.341 | —0 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
10.11
Earnings Yield (E/P)
0.0989
Price / Sales
1.16
Price / Book
0.94
Price / Cash Flow
702.22
FCF Yield
-4.3%
EBITDA / EV
16.2%
Sales Yield (1/P·S)
0.7958
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
9.3%
Return on Assets
6.8%
Net Margin
11.5%
Operating Margin
2.5%
Gross Profit / Assets
Novy-Marx GPA
31.6%
Current Ratio
2.48
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.067
MomentumPrice trend strength over different horizons
6M Return
-18.5%
12M Return
-38.8%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-34.9%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-1.02
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
4.3%
Earnings Growth (YoY)
83.9%
Earnings Stability (CV)
Lower = more stable
1.905
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
19
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
19
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
15
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity